Skip to main content Back to Top
Advertisement

6/5/2020

Enoxaparin Sodium Injection

Products Affected - Description

    • Lovenox injection, Sanofi-Aventis, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00075-2912-01
    • Lovenox injection, Sanofi-Aventis, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00075-0621-60

Reason for the Shortage

    • Amphastar has enoxaparin available.
    • Apotex has enoxaparin available.
    • Fresenius Kabi has enoxaparin available. Fresenius Kabi updated NDC numbers of the 80 mg and 100 mg prefilled syringes in October 2019.
    • Sanofi-Aventis did not provide a reason for the shortage.
    • Teva has enoxaparin available.
    • Winthrop has enoxaparin available.

Available Products

    • Lovenox injection, Sanofi-Aventis, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00075-0623-00
    • Lovenox injection, Sanofi-Aventis, 100 mg/ 1 mL, 3 mL multiple dose vial, 1 count, NDC 00075-0626-03
    • Lovenox injection, Sanofi-Aventis, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00075-2915-01
    • Lovenox injection, Sanofi-Aventis, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00075-0624-30
    • Lovenox injection, Sanofi-Aventis, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00075-0620-40
    • Lovenox injection, Sanofi-Aventis, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00075-0622-80
    • Enoxaparin sodium injection, Amphastar, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00548-5605-00
    • Enoxaparin sodium injection, Amphastar, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00548-5606-00
    • Enoxaparin sodium injection, Amphastar, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00548-5607-00
    • Enoxaparin sodium injection, Amphastar, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00548-5601-00
    • Enoxaparin sodium injection, Amphastar, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00548-5602-00
    • Enoxaparin sodium injection, Amphastar, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00548-5603-00
    • Enoxaparin sodium injection, Amphastar, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00548-5604-00
    • Enoxaparin sodium injection, Apotex, 100 mg/ 1 mL, 1 mL prefilled syringe, 10 count, NDC 60505-0796-04
    • Enoxaparin sodium injection, Apotex, 120 mg/ 0.8 mL, 0.8 mL prefilled syringe, 10 count, NDC 60505-0795-04
    • Enoxaparin sodium injection, Apotex, 150 mg/ 1 mL, 1 mL prefilled syringe, 10 count, NDC 60505-0798-04
    • Enoxaparin sodium injection, Apotex, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 60505-0791-04
    • Enoxaparin sodium injection, Apotex, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 60505-0792-04
    • Enoxaparin sodium injection, Apotex, 60 mg/ 0.6 mL, 0.6 mL prefilled syringe, 10 count, NDC 60505-0793-04
    • Enoxaparin sodium injection, Apotex, 80 mg/ 0.8 mL, 0.8 mL prefilled syringe, 10 count, NDC 60505-0794-04
    • Enoxaparin sodium injection, Fresenius Kabi, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 63323-0605-84
    • Enoxaparin sodium injection, Fresenius Kabi, 100 mg/ 1 mL, 3 mL multiple dose vial, 1 count, NDC 63323-0565-86
    • Enoxaparin sodium injection, Fresenius Kabi, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 63323-0569-90
    • Enoxaparin sodium injection, Fresenius Kabi, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 63323-0569-84
    • Enoxaparin sodium injection, Fresenius Kabi, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 63323-0568-83
    • Enoxaparin sodium injection, Fresenius Kabi, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 63323-0568-87
    • Enoxaparin sodium injection, Fresenius Kabi, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 63323-0568-88
    • Enoxaparin sodium injection, Fresenius Kabi, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 63323-0531-90
    • Enoxaparin sodium injection, Teva, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00703-8580-23
    • Enoxaparin sodium injection, Teva, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00703-8610-23
    • Enoxaparin sodium injection, Teva, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00703-8510-23
    • Enoxaparin sodium injection, Teva, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00703-8530-23
    • Enoxaparin sodium injection, Teva, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00703-8540-23
    • Enoxaparin sodium injection, Teva, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00703-8560-23
    • Enoxaparin sodium injection, Teva, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00703-8680-23
    • Enoxaparin sodium injection, Winthrop, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00955-1010-10
    • Enoxaparin sodium injection, Winthrop, 100 mg/ 1 mL, 3 mL multiple dose vial, 1 count, NDC 00955-1016-01
    • Enoxaparin sodium injection, Winthrop, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00955-1012-10
    • Enoxaparin sodium injection, Winthrop, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00955-1015-10
    • Enoxaparin sodium injection, Winthrop, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00955-1003-10
    • Enoxaparin sodium injection, Winthrop, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00955-1004-10
    • Enoxaparin sodium injection, Winthrop, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00955-1006-10
    • Enoxaparin sodium injection, Winthrop, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00955-1008-10

Estimated Resupply Dates

    • Sanofi-Aventis has Lovenox 120 mg/0.8 mL available with short expiration dating. Lovenox 60 mg/0.6 mL prefilled syringes are on intermittent back order and the company estimates product will be allocated in mid-June 2020.

Updated

Updated June 5, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 7, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.